Nitrendipine Prevents the Development of Cardiac Hypertrophy in DOCA-Salt-Treated Hypertension-Prone (SBH) and -Resistant (SBN) Rats Through Nonhemodynamic Mechanisms.

MLA

Kobrin, I., et al. “Nitrendipine Prevents the Development of Cardiac Hypertrophy in DOCA-Salt-Treated Hypertension-Prone (SBH) and -Resistant (SBN) Rats Through Nonhemodynamic Mechanisms.” Journal of Cardiovascular Pharmacology, vol. 12, July 1988, pp. S125–28. EBSCOhost, https://doi.org/10.1097/00005344-198806124-00027.

APA

Kobrin, I., Waksman, R., Mekler, J., Eimerl, J., & Ben-Ishay, D. (1988). Nitrendipine Prevents the Development of Cardiac Hypertrophy in DOCA-Salt-Treated Hypertension-Prone (SBH) and -Resistant (SBN) Rats Through Nonhemodynamic Mechanisms. Journal of Cardiovascular Pharmacology, 12, S125–S128. https://doi.org/10.1097/00005344-198806124-00027

Chicago

Kobrin, I., R. Waksman, J. Mekler, J. Eimerl, and D. Ben-Ishay. 1988. “Nitrendipine Prevents the Development of Cardiac Hypertrophy in DOCA-Salt-Treated Hypertension-Prone (SBH) and -Resistant (SBN) Rats Through Nonhemodynamic Mechanisms.” Journal of Cardiovascular Pharmacology 12 (July): S125–28. doi:10.1097/00005344-198806124-00027.